Publicacións (30) Publicacións de ANDREA LOPEZ LOPEZ

2023

  1. Impact of Hyperkalemia in Heart Failure and Reduced Ejection Fraction: A Retrospective Study

    Journal of Clinical Medicine, Vol. 12, Núm. 10

  2. Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia

    Antioxidants, Vol. 12, Núm. 7

2022

  1. Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures

    Antioxidants, Vol. 11, Núm. 2

  2. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

    Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273

  3. Cardiac amyloidosis: Description of a series of 143 cases

    Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213

  4. Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes

    Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428

2021

  1. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria

    Redox Biology, Vol. 46

  2. Nadph-oxidase, rho-kinase and autophagy mediate the (Pro)renin-induced pro-inflammatory microglial response and enhancement of dopaminergic neuron death

    Antioxidants, Vol. 10, Núm. 9

2020

  1. Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA

    Frontiers in Neuroanatomy, Vol. 14

  2. Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease

    British Journal of Pharmacology, Vol. 177, Núm. 24, pp. 5622-5641

2019

  1. Carotid plaque is a predictor of major adverse cardiac and cerebrovascular events in patients undergoing coronary angiography

    Archivos de Cardiologia de Mexico, Vol. 89, Núm. 1, pp. 1-7

  2. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study

    Journal of Gastroenterology and Hepatology (Australia), Vol. 34, Núm. 1, pp. 277-283

  3. Usefulness of carotid ultrasonography in the assessment of coronary artery disease extension in patients undergoing exercise echocardiography

    Echocardiography, Vol. 36, Núm. 2, pp. 336-344

2018

  1. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis

    Journal of Clinical Gastroenterology, Vol. 52, Núm. 8, pp. e63-e72

2017

  1. Percutaneous Coronary Intervention and Cardiac Surgery in Cancer Patients

    Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions (Elsevier Inc.), pp. 357-362

2016

  1. Benefício a longo prazo do tratamento com inibidores da enzima de conversão da angiotensina ou antagonistas do recetor da angiotensina, após intervenção coronária percutânea bem-sucedida, no enfarte agudo do miocárdio sem elevação do segmento ST

    Revista Portuguesa de Cardiologia, Vol. 35, Núm. 12, pp. 645-653

  2. El riesgo de eventos cardiovasculares tras un evento coronario agudo persiste elevado a pesar de la revascularización, especialmente durante el primer año

    Revista Espanola de Cardiologia, Vol. 69, Núm. 1, pp. 11-18

  3. RETRACTED ARTICLE: Long-term mortality prediction of CHA2DS2VASc and HATCH scores in a cohort of patients with typical atrial flutter

    Clinical Research in Cardiology, Vol. 105, Núm. 4, pp. 377

2015

  1. Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 15, Núm. 1

  2. Evaluation of SAMe-TT<inf>2</inf>R<inf>2</inf> risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists

    Europace, Vol. 17, Núm. 5, pp. 711-717